Severe agranulocytosis in patient with Graves’ disease on second exposure to carbimazole
For half a century, antithyroid drugs (ATDs) have been the first-line treatment for Graves’ disease. ATDs, e.g. carbimazole, are associated with minor and serious adverse effects. These include rash, urticaria, arthralgia, hepatotoxicity, vasculitis, and agranulocytosis. Agranulocytosis is a potenti...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Bioscientifica
2026-03-01
|
| Rangatū: | Endocrinology, Diabetes & Metabolism Case Reports |
| Ngā marau: | |
| Urunga tuihono: | https://edm.bioscientifica.com/view/journals/edm/2026/1/EDM-25-0131.xml |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|